Inventor · disambiguated record
Rajeev Jain
Also filed as: JAIN RAJEEV · JAIN RAJEEV A
13 granted patents·34 pending applications·854 citations·filing 1998–2025
94Inventor score
Files withELAN PHARMA INT LTD26ACUSPHERE INC4FOURNIER LAB IRELAND LTD3RHODES PHARMACEUTICALS LP3SWANSON JON2
Top patents by PatentIndex Score
47 records- 0195US6316029B1Rapidly disintegrating solid oral dosage formFLAK PHARMA INTERNATIONAL LTD·Filed 2000·Granted Nov 13, 2001·412 cites·70 claims
- 0294US7320802B2Methods of treatment using nanoparticulate fenofibrate compositionsELAN PHARMA INT LTD·Filed 2003·Granted Jan 22, 2008·54 cites·396 claims
- 0394US7198795B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositionsELAN PHARMA INT LTD·Filed 2002·Granted Apr 3, 2007·62 cites·19 claims
- 0493US7276249B2Nanoparticulate fibrate formulationsFOURNIER LAB IRELAND LTD·Filed 2003·Granted Oct 2, 2007·61 cites·189 claims
- 0593US6165506ASolid dose form of nanoparticulate naproxenELAN PHARMA INT LTD·Filed 1998·Granted Dec 26, 2000·190 cites·21 claims
- 0688US7695739B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositionsELAN PHARMA INT LTD·Filed 2007·Granted Apr 13, 2010·6 cites·18 claims
- 0787US7927627B2Nanoparticulate fibrate formulationsELAN PHARMA INT LTD·Filed 2007·Granted Apr 19, 2011·7 cites·20 claims
- 0885US7998507B2Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitorsELAN PHARMA INT LTD·Filed 2005·Granted Aug 16, 2011·6 cites·35 claims
- 0984US7931917B2Nanoparticulate fibrate formulationsELAN PHARMA INT LTD·Filed 2007·Granted Apr 26, 2011·5 cites·30 claims
- 1082US8309136B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositionsCOOPER EUGENE R·Filed 2010·Granted Nov 13, 2012·3 cites·14 claims
- 1179US8293277B2Controlled-release nanoparticulate compositionsSWANSON JON·Filed 1999·Granted Oct 23, 2012·45 cites·28 claims
- 1276US11564918B2Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2017·Granted Jan 31, 2023·2 cites·24 claims
- 1375US2025352538A1Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2025·Application pending·0 cites
- 1472US2009130213A1Rapidly disintegrating solid oral dosage formELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 1572US2008213371A1Rapidly disintegrating solid oral dosage formELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 1669US2023125208A1Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 1766US2009297619A1Nanoparticulate anticonvulsant and immunosuppressive compositionsELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 1865US8236352B2Glipizide compositionsBOSCH H WILLIAM·Filed 2003·Granted Aug 7, 2012·1 cites·49 claims
- 1963US2005079138A1Methods for making pharmaceutical formulations comprising microparticles with improved dispersibility, suspendability or wettabilityFiled 2004·Application pending·0 cites
- 2063US2004057993A1Rapidly disintegrating solid oral dosage formELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 2163US2012114754A1Rapidly disintegrating solid oral dosage formJAIN RAJEEV A·Filed 2011·Application pending·0 cites
- 2262US2008248123A1Nanoparticulate anticonvulsant and immunosuppressive compositionsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 2361US2008124393A1Controlled release nanoparticulate compositionsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2461US2008138424A1Nanoparticulate fibrate formulationsFOURNIER LAB IRELAND LTD·Filed 2007·Application pending·0 cites
- 2561US2008279949A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 2660US2008226732A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2760US2008107741A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2860US2008050461A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2959US2010062066A1Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral AdministrationACUSPHERE INC·Filed 2007·Application pending·0 cites
- 3058US2007048378A1Nanoparticulate anticonvulsant and immunosuppressive compositionsELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 3157US2025352521A1Fixed dosage antibiotic compositionsENTASIS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 3256US2007264348A1Nanoparticulate fibrate formulationsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 3356US2004013613A1Rapidly disintegrating solid oral dosage formFiled 2001·Application pending·0 cites
- 3454US2007148211A1Processes for making particle-based pharmaceutical formulations for oral administrationACUSPHERE INC·Filed 2006·Application pending·0 cites
- 3554US2007178165A1Processes for making particle-based pharmaceutical formulations for parenteral administrationACUSPHERE INC·Filed 2006·Application pending·0 cites
- 3653US2007178166A1Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administrationACUSPHERE INC·Filed 2006·Application pending·0 cites
- 3753US2011300210A1Controlled release nanoparticulate clozapine compositionsSWANSON JON·Filed 2011·Application pending·0 cites
- 3852US2010329976A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2010·Application pending·0 cites
- 3952US2010322852A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2010·Application pending·0 cites
- 4052US2010322853A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2010·Application pending·0 cites
- 4152US2013011447A1Controlled release nanoparticulate compositionsALKERMES PHARMA IRELAND LTD·Filed 2012·Application pending·0 cites
- 4251US2004033267A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 4347US2008241070A1Fenofibrate dosage formsFOURNIER LAB IRELAND LTD·Filed 2008·Application pending·0 cites
- 4444US2008220075A1Nanoparticulate compositions of angiogenesis inhibitorsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 4544US2012251613A1Method for treating vitiligo with a prostaglandin analogueJAIN RAJEEV·Filed 2011·Application pending·0 cites
- 4642US2003224058A1Nanoparticulate fibrate formulationsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 4738US2003181411A1Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitorsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →